fbpx

molecules of the month

BI-3406

potent and selective SOS1/KRAS inhibitor

related cmpd in Ph. I for KRAS+ cancers

from biochemical HTS and SBDD

Cancer Discovery, Aug. 19, 2020

Boehringer Ingelheim, Vienna, AT

Structure of BI-3406
1 min read

BI-3406 is a compound which binds to SOS1, preventing it from activating the oncoprotein KRAS. While inhibition of WT-KRAS and MEK alone are anticipated to be toxic, the combination of a SOS1 inhibitor with a MEK inhibitor appears to have a broader therapeutic index due to synergy in KRAS-driven tumors. A related undisclosed SOS1 inhibitor, BI 1701963, is in clinical development alone and in combination with a MEK inhibitor.


request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.


already a member? log in: